Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Watson Pharmaceuticals Inc Completes Acquisition Of Actavis Group


Wednesday, 31 Oct 2012 07:45pm EDT 

Watson Pharmaceuticals Inc announced that it has completed the acquisition of the Actavis Group for EUR4.25 billion. Watson funded the transaction through a combination of $1.8 billion in term loan borrowings and the issuance of $3.9 billion in senior unsecured notes. 

Company Quote

216.37
0.24 +0.11%
22 Jul 2014